Better Science Through Imaging

There is a clear call to automate manufacturing for cell and gene therapy products, but when should you automate? In this session, we will consider the shifting priorities as you move from product development towards clinical manufacturing and discuss how choosing the right type of automation can create immediate impact without compromising flexibility. Case studies in adherent and suspension cell expansion, gene modification and cell secretome production will be presented.

To ensure patient safety, regulatory agencies mandate mycoplasma testing for the release of products. Conventional mycoplasma testing takes at least 28 days, resulting.

In this webinar, Marie Piketty recalls that in recent years, several cases of interference caused by Biotin have been reported, concerning doses of thyroid hormones, but also other hormones, and other dosages. Biotin also called Vitamin B7, is a cofactor of several reactions to the carboxylase. Biotin present in multivitamin cocktails, does not present a risk of interference, but the use of Biotin at supraphysiological doses as a product of "beauty" (for hair, nails and skin), or at high doses as treatment in patients with multiple sclerosis can cause interference.

Upgrading the CRISPR Toolbox - New Strategies Sharpen the CRISPR-Cas9 Scissors Utilizing Visualization and Chromatic Accessibility